Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (18)
P 1 (3)
P 2 (4)
P 4 (1)

Trial Status

Recruiting20
Completed8
Not Yet Recruiting7
Enrolling By Invitation2
Terminated2
Active Not Recruiting2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT07038369Phase 1Active Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07735962Not ApplicableRecruiting

Prophylactic Subcutaneous Drainage After Gynecologic Oncology Midline Laparotomy

NCT07216456Not ApplicableRecruiting

Vaginal Dilator Therapy After Pelvic Radiation

NCT07055854Phase 1RecruitingPrimary

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

NCT07313839Not ApplicableRecruitingPrimary

Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)

NCT07642531Not ApplicableNot Yet Recruiting

A Modular Cloud Platform For Fertility Preservation

NCT07039526Phase 2Recruiting

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

NCT06904339Not ApplicableRecruitingPrimary

Communication About Sexual Health in Gynecologic Cancer

NCT07024784Phase 2RecruitingPrimary

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

NCT07594327Enrolling By Invitation

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

NCT01034033Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT07586826Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

NCT07580651Not ApplicableNot Yet Recruiting

Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring

NCT07573787Not ApplicableTerminatedPrimary

Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Disorders

NCT07557342Recruiting

Assessment of Sexual Well-being in Patients With Gynecologic Cancer and Their Partners: the ONCOSEX Study

NCT07327125Not ApplicableRecruitingPrimary

Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery

NCT07497802Not ApplicableNot Yet RecruitingPrimary

Mindfulness-Based Psychoeducation for Women With Gynecological Cancer

NCT07483905Not Yet RecruitingPrimary

Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients

NCT07121738Not ApplicableRecruitingPrimary

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

NCT07406789Phase 2Not Yet RecruitingPrimary

Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).

Scroll to load more

Research Network

Activity Timeline